Axogen (AXGN) Short-term Investments (2010 - 2026)
Axogen's (AXGN) quarterly Short-term Investments came in at $18.9 million in Q1 2026, up 376.89% year-on-year from $4.0 million in Q1 2025, and up 216.84% quarter-over-quarter from $6.0 million in Q4 2025.
Axogen (AXGN) Short-term Investments (2010 - 2026) Analysis & Trends
Axogen's Short-term Investments history runs 11 years deep, the most recent figure standing at $18.9 million for Q1 2026.
- On a quarterly basis, Short-term Investments rose 376.89% year-over-year to $18.9 million in Q1 2026; TTM through Mar 2026 was $18.9 million, a 376.89% increase from a year earlier, with the FY2025 full-year figure at $6.0 million, up 0.88% from the prior year.
- Short-term Investments climbed to $18.9 million in Q1 2026 per AXGN's latest filing, from $6.0 million in the prior quarter.
- Across five years, Short-term Investments topped out at $52.9 million in Q1 2022 and bottomed at $1.5 million in Q3 2023.
- The 5-year median for Short-term Investments is $10.6 million (2023), against an average of $17.5 million.
- Across the five-year window, Short-term Investments sank 96.15% in 2023 and surged 408.54% in 2025, its largest moves.
- Year by year, Short-term Investments stood at $33.5 million in 2022, then sank by 95.54% to $1.5 million in 2023, then surged by 296.79% to $5.9 million in 2024, then grew by 0.88% to $6.0 million in 2025, then surged by 216.84% to $18.9 million in 2026.
- Per Business Quant, the three latest AXGN Short-term Investments figures stand at $18.9 million (Q1 2026), $6.0 million (Q4 2025), and $11.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.95 Mn |
| Dec 31, 2025 | 5.98 Mn |
| Sep 30, 2025 | 11.89 Mn |
| Jun 30, 2025 | 9.89 Mn |
| Mar 31, 2025 | 3.97 Mn |
| Dec 31, 2024 | 5.93 Mn |
| Sep 30, 2024 | 5.87 Mn |
| Jun 30, 2024 | 1.94 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 11.31 Mn |
| Mar 31, 2023 | 30.16 Mn |
| Dec 31, 2022 | 33.51 Mn |
| Sep 30, 2022 | 38.79 Mn |
| Jun 30, 2022 | 46.21 Mn |
| Mar 31, 2022 | 52.86 Mn |
| Dec 31, 2021 | 51.33 Mn |
| Sep 30, 2021 | 44.99 Mn |
| Jun 30, 2021 | 46.84 Mn |
| Mar 31, 2021 | 51.06 Mn |